Business
Court Approval
Court Approval.
About this update from Surgical Innovations Group Plc
[{"type":"text","content":"\n RNS Number : 4870P Surgical Innovations Group PLC 16 July 2010 \n \n\n \n\n\n\n\nPress Release\n\n\n16 July 2010\n\n\n\n\n \nSurgical Innovations Group plc\n \n(\"SI\" or \"the Group\")\n \n Court Approval \n \nSurgical Innovations Group plc (AIM: SUN), the designer and manufacturer of innovative surgical devices, is pleased to announce that on 15 July 2010, the Court approved its application for the cancellation of its share premium account through the offsetting of accumulated losses.\n \n- Ends -\n \nFor further information:\n\n\n\n\nSurgical Innovations Group plc\n\n\n\n\n\n\n\nDoug Liversidge, Chairman\n\n\nTel: +44 (0) 113 230 7597\n\n\n\n\n\n\n\nwww.surginno.com \n\n\n\n\nGraham Bowland, Chief Executive Officer\n\n\nTel: +44 (0) 113 230 7597\n\n\n\n\[email protected] \n\n\nwww.surginno.com \n\n\n\n\n \n\n\n\n\nWesthouse Securities Limited\n\n\n\n\n\n\n\nTim Feather / Matthew Johnson\n\n\nTel: +44 (0) 113 246 2611\n\n\n\n\[email protected] \n\n\nwww.westhousesecurities.com \n\n\n\n\n \nMedia enquiries:\n\n\n\n\nThe Communications Portfolio\n\n\n\n\n\n\n\nAriane Comstive\n\n\nTel: +44 (0)20 7536 2028\n\n\n\n\[email protected]\n\n\nwww.communicationsportfolio.co.uk \n\n\n\n\n \n \nNotes to Editors:\nAbout Surgical Innovations Group plc\nSurgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets. The Group has two divisions; Surgical Innovations Limited and Haemocell Limited.\n \nThe Group employs over 100 people at its 32,000 square feet facility in Leeds, with in-house design and the manufacturing of products to the highest quality standards. Through an established network of distribution partners, SI sells in all major medical markets including North America, Europe, South Africa, the Middle East, South-East Asia and Australia. \n \nSurgical Innovations Limited, the main trading subsidiary of the Group, is focused on developing medical instruments for the laparoscopic surgery market - minimally invasive surgery of the abdomen. The Group has pioneered Resposable® instrumentation combining both single use and reusable components ensuring an ongoing revenue...